Robin.Zhang.Headshot.

Robin R. Zhang

Associate

Robin Zhang helps companies navigate the complex legal landscape to achieve their goals. Robin works in our Business Law Department, specializing in the Transactions Practice Group. He is based in the Silicon Valley office. Robin began at Foley as a summer associate in 2022, where he worked on projects related to venture capital funding, as well as corporate formation and governance. He also assisted in drafting investment agreements and corporate compliance documents. Robin previously interned at a Business Law firm in Menlo Park and an IP Law firm in China. His previous experiences include conducting research for statutes and court decisions for use in amicus briefs and performing due diligence for mergers and acquisitions. In law school, Robin worked as a research assistant focused on cross-border choice-of-law issues.

28 January 2025 Deals and Wins

Foley Advises Nema Health in $14.5M Series A

Foley & Lardner LLP represented Nema Health, a multi-state digital health company focused on providing intensive, evidence-based treatment for post-traumatic stress disorder (PTSD), in its $14.5 million Series A funding led by Deerfield Management alongside CVS Health Ventures. Optum Ventures, .406 Ventures, and GreyMatter also participated.
17 January 2025 Deals and Wins

Foley Represents BosonQ Psi in Seed Financing Round

Foley & Lardner LLP represented BosonQ Psi, a pioneer in quantum-inspired simulation technology, in raising over $3 million in its seed financing round.
09 January 2025 Deals and Wins

Foley Represents TCGX and Omega Funds in $207.5M Series C Financing for Aviceda Therapeutics

Foley & Lardner LLP represented TCG Crossover (TCGX) and Omega Funds as lead investors in the $207.5 million Series C financing for Aviceda Therapeutics (Aviceda).
20 December 2024 Deals and Wins

Foley Represents Wine Access in Acquisition by Full Glass Wine Co.

Foley & Lardner LLP represented Wine Access, a leading online platform for discovering and purchasing premium wines and a Norwest Venture Partners portfolio company, in their acquisition by Full Glass Wine Co., a rapidly growing direct-to-consumer wine company.
17 September 2024 Deals and Wins

Foley Represents TCGX as Lead Investor in $105M Series B Financing for Pathalys Pharma

Foley & Lardner LLP represented TCG Crossover (TCGX) as the lead investor in the $105 million Series B financing for Pathalys Pharma Inc., a private biopharmaceutical company in the late stages of developing treatments for kidney disease.
06 May 2024 Deals and Wins

Foley Represents Boviet Solar in Acquisition of First US Production Facility

Foley & Lardner LLP recently represented Boviet Solar Technology Co., Ltd. (Boviet Solar) in the acquisition of its first North America production facility in Greenville, North Carolina.